Pascal and Francis Bibliographic Databases

Help

Search results

Your search

jo.\*:("Current pharmaceutical design")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 3150

  • Page / 126
Export

Selection :

  • and

Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human ObesityHEILBRONN, Leonie K; CAMPBELL, Lesley V.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1225-1230, issn 1381-6128, 6 p.Article

Advanced Glycation End Products and Insulin Resistance : Advanced glycation end products (AGEs) and their receptor (RAGE) in health and diseaseUNOKI, Hiroyuki; YAMAGISHI, Sho-Ichi.Current pharmaceutical design. 2008, Vol 14, Num 10, pp 987-989, issn 1381-6128, 3 p.Article

Animal Models of Diabetes Mellitus : Relevance to Vascular Complications : Experimental Models for the Study of Drugs Used to Prevent and Treat Vascular DiseasesTHOMPSON, Cecil S.Current pharmaceutical design. 2008, Vol 14, Num 4, pp 309-324, issn 1381-6128, 16 p.Article

Cyclooxygenase-2 in Synaptic Signaling : Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric DiseasesHONGWEI YANG; CHU CHEN.Current pharmaceutical design. 2008, Vol 14, Num 14, pp 1443-1451, issn 1381-6128, 9 p.Article

Different Types of Cell Death in Organismal Aging and Longevity : State of the Art and Possible Systems Biology Approach : Mechanisms of Cell Death: Biomedical ImplicationsSALVIOLI, Stefano; CAPRI, Miriam; BELLAVISTA, Elena et al.Current pharmaceutical design. 2008, Vol 14, Num 3, pp 226-236, issn 1381-6128, 11 p.Article

Drug Eluting Stents and BeyondRASTOGI, Ashish; STAVCHANSKY, Salomon.Current pharmaceutical design. 2008, Vol 14, Num 21, pp 2111-2120, issn 1381-6128, 10 p.Article

Engineering Silica Particles as Oral Drug Delivery VehiclesRIGBY, S. P; FAIRHEAD, M; VAN DER WALLE, C. F et al.Current pharmaceutical design. 2008, Vol 14, Num 18, pp 1821-1831, issn 1381-6128, 11 p.Article

Factor Xa Inactivation in Acute Coronary Syndrome : Drugs in interventional cardiologyBARANTKE, Melanie; BONNEMEIER, Hendrik.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1186-1190, issn 1381-6128, 5 p.Article

Fibrate-Associated Adverse Effects Beyond Muscle and Liver ToxicityFLORENTIN, M; LIBEROPOULOS, E. N; MIKHAILIDIS, D. P et al.Current pharmaceutical design. 2008, Vol 14, Num 6, pp 574-587, issn 1381-6128, 14 p.Article

Genomics Can Advance The Potential For Probiotic Cultures To Improve Liver And Overall Health : Prebiotics and Probiotics Delivering Therapeutics as Dietary ComponentsO'SULLIVAN, Daniel J.Current pharmaceutical design. 2008, Vol 14, Num 14, pp 1376-1381, issn 1381-6128, 6 p.Article

Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins) : Histone Deacetylase InhibitorsNEUGEBAUER, Robert C; SIPPI, Wolfgang; JUNG, Manfred et al.Current pharmaceutical design. 2008, Vol 14, Num 6, pp 562-573, issn 1381-6128, 12 p.Article

Models for the Study of Angiogenesis : Experimental Models for the Study of Drugs Used to Prevent and Treat Vascular DiseasesSHIBA, Yuji; TAKAHASHI, Masafumi; IKEDA, Uichi et al.Current pharmaceutical design. 2008, Vol 14, Num 4, pp 371-377, issn 1381-6128, 7 p.Article

Non Steroidal Anti-Inflammatory Drugs and Neurogenesis in the Adult Mammalian Brain : Cyclooxygenases and Cyclooxygenase Inhibitors in Neurological and Psychiatric DiseasesANTONIETTA AJMONE-CAT, Maria; CACCI, Emanuele; MINGHETTI, Luisa et al.Current pharmaceutical design. 2008, Vol 14, Num 14, pp 1435-1442, issn 1381-6128, 8 p.Article

Pharmacoeconomics of Anticoagulants in Acute Coronary Syndrome and Percutaneous Coronary Intervention : Drugs in interventional cardiologyHUSTON, S. A; HAWKINS, D.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1197-1204, issn 1381-6128, 8 p.Article

Pharmacological Therapy in Children with Atrioventricular Reentry : Which Drug? : Current trends in the treatment of supraventricular tachycardia in pediatric ageRATNASAMY, Christopher; ROSSIQUE-GONZALEZ, Marie; YOUNG, Ming-Lon et al.Current pharmaceutical design. 2008, Vol 14, Num 8, pp 753-761, issn 1381-6128, 9 p.Article

Pharmacological Therapy in Children with Nodal Reentry Tachycardia : When, How and How Long to Treat the Affected Patients : Current trends in the treatment of supraventricular tachycardia in pediatric ageBOUHOUCH, R; EL HOUARI, T; FELLAT, I et al.Current pharmaceutical design. 2008, Vol 14, Num 8, pp 766-769, issn 1381-6128, 4 p.Article

Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4ZHOU, Shu-Feng.Current pharmaceutical design. 2008, Vol 14, Num 10, pp 990-1000, issn 1381-6128, 11 p.Article

Rodent Models of Hemorrhagic Stroke : Experimental Models for the Study of Drugs Used to Prevent and Treat Vascular DiseasesSTRBIAN, D; DURUKAN, A; TATLISUMAK, T et al.Current pharmaceutical design. 2008, Vol 14, Num 4, pp 352-358, issn 1381-6128, 7 p.Article

Role of Toll-Like Receptors in Immune Responses to Chlamydial InfectionsJOYEE, A. G; XI YANG.Current pharmaceutical design. 2008, Vol 14, Num 6, pp 593-600, issn 1381-6128, 8 p.Article

Safety and Efficacy of Bivalirudin in Acute Coronary Syndromes : Drugs in interventional cardiologyHARTMANN, F.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1191-1196, issn 1381-6128, 6 p.Article

Targeting Cyclooxygenase-2 in Hematological Malignancies : Rationale and Promise : Innovative therapeutical approaches for hematological malignancies based on molecular target therapiesBERNARD, M. P; BANCOS, S; SIME, P. J et al.Current pharmaceutical design. 2008, Vol 14, Num 21, pp 2051-2060, issn 1381-6128, 10 p.Article

The Protective Role of Steroids in Ischemia-Reperfusion Injury of the LiverPULITANO, Carlo; ALDRIGHETTI, Luca.Current pharmaceutical design. 2008, Vol 14, Num 5, pp 496-503, issn 1381-6128, 8 p.Article

Type 2 Transglutaminase in Neurodegenerative Diseases : The Mitochondrial Connection : Mechanisms of Cell Death: Biomedical ImplicationsMALORNI, Walter; GRAZIA FARRACE, Maria; RODOLFO, Carlo et al.Current pharmaceutical design. 2008, Vol 14, Num 3, pp 278-288, issn 1381-6128, 11 p.Article

Cell Death in the IPLB-LdFB Insect Cell Line : Facts and ImplicationsMALAGOLI, D.Current pharmaceutical design. 2008, Vol 14, Num 2, pp 126-130, issn 1381-6128, 5 p.Article

Anti-Cancer DrugsBERGMANN-LEITNER, Elke.Current pharmaceutical design. 2008, Vol 14, Num 11, issn 1381-6128, 104 p.Serial Issue

  • Page / 126